- Home
- TEAM vs A Comparison
TEAM vs A Comparison
Compare TEAM & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEAM | A |
|---|---|---|
| Founded | 2002 | 1999 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.5B | 38.0B |
| IPO Year | 2015 | 1999 |
Fundamental Metrics
Financial Performance| Metric | TEAM | A |
|---|---|---|
| Price | $196.06 | $168.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 15 |
| Target Price | ★ $169.18 | $161.47 |
| AVG Volume (30 Days) | ★ 3.2M | 1.6M |
| Earning Date | 04-30-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | ★ 78.57 | 3.16 |
| EPS | N/A | ★ 3.55 |
| Revenue | ★ $6,572,308,000.00 | $4,472,000,000.00 |
| Revenue This Year | $24.65 | $8.45 |
| Revenue Next Year | $17.67 | $6.13 |
| P/E Ratio | ★ N/A | $47.11 |
| Revenue Growth | ★ 26.02 | 6.43 |
| 52 Week Low | $56.01 | $108.35 |
| 52 Week High | $200.00 | $167.59 |
Technical Indicators
Market Signals| Indicator | TEAM | A |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | N/A |
| Support Level | $158.71 | N/A |
| Resistance Level | $198.60 | N/A |
| Average True Range (ATR) | 7.68 | 0.00 |
| MACD | -2.14 | 0.00 |
| Stochastic Oscillator | 61.23 | 0.00 |
Price Performance
Historical ComparisonAbout TEAM Atlassian Corporation
Atlassian produces software that helps teams work together more efficiently and more effectively. The company provides project planning and management software, collaboration tools, and service desk solutions. Atlassian was founded in 2002 and is headquartered in Sydney, Australia.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.